Ligand validation:3C3D

FO1: 1-deoxy-1-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol

FO1 is a Ligand Of Interest in 3C3D designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3C3D_FO1_A_401	54%	2%	0.156	0.964	3.97	2.95	13	14	0	0	77%	0.6692
3C3D_FO1_D_401	52%	2%	0.153	0.953	3.93	2.93	13	15	0	0	77%	0.6692
3C3D_FO1_C_401	46%	2%	0.176	0.954	4.08	2.92	13	14	0	0	77%	0.6692
3C3D_FO1_B_401	45%	2%	0.177	0.95	4.04	2.88	13	14	0	0	77%	0.6692
3C3E_FO1_C_401	5%	1%	0.42	0.893	5.84	2.29	16	11	0	0	65%	0.5231
4CDN_FO1_B_999	77%	21%	0.115	0.955	1.5	1.81	5	10	0	0	100%	1
3CVV_FO1_A_522	73%	19%	0.129	0.956	2.1	1.4	6	8	0	0	100%	1
3CVW_FO1_A_1422	33%	6%	0.242	0.924	1.86	3.26	5	10	0	0	100%	1
4CDM_FO1_A_1464	23%	24%	0.261	0.885	1.66	1.46	5	6	1	0	100%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.